Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Fey

Showing results (141-150 of 271) with videos related to

Pageof 28
Sort By:
Genomics|April 1, 1989
Analysis of somatic mutations at human minisatellite loci in tumors and cell linesJ A Armour, I Patel, S L Thein, et al.
Journal of Leukocyte Biology|May 21, 2015
Low DICER1 expression is associated with attenuated neutrophil differentiation and autophagy of NB4 APL cellsJulian Wampfler, Elena A Federzoni, Bruce E Torbett, et al.
British Journal of Cancer|April 19, 2014
Effects of erythropoiesis-stimulating agents on fatigue- and anaemia-related symptoms in cancer patients: systematic review and meta-analyses of published and unpublished dataJ Bohlius, T Tonia, E Nüesch, et al.
Leukemia|November 2, 2007
The hDMP1 tumor suppressor is a new WT1 target in myeloid leukemiasM P Tschan, U Gullberg, D Shan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 18, 2012
MicroRNA-381 represses ID1 and is deregulated in lung adenocarcinomaSacha I Rothschild, Mario P Tschan, Rolf Jaggi, et al.
British Journal of Haematology|November 25, 1998
Sampling bias and logistical problems of molecular analyses in a clinical leukaemia trial. Swiss Group for Clinical Cancer Research (SAKK)M F Fey, M Blaser, M Wernli, et al.
Lung Cancer (Amsterdam, Netherlands)|July 4, 2016
MicroRNA-106a targets autophagy and enhances sensitivity of lung cancer cells to Src inhibitorsSacha I Rothschild, Oliver Gautschi, Jasmin Batliner, et al.
Future Oncology (London, England)|February 5, 2014
Crizotinib inhibits migration and expression of ID1 in MET-positive lung cancer cells: implications for MET targeting in oncologyEmanuel Stutz, Oliver Gautschi, Martin F Fey, et al.
Blood|April 15, 1995
Interleukin-12 expression in human lymphomas and nonneoplastic lymphoid disordersJ Schwaller, A Tobler, G Niklaus, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|January 1, 1991
[Large cell anaplastic lymphomas in the immunocompromised host]B Borisch, M F Fey, A Tobler, et al.
Pageof 28

Showing results (141-150 of 271) with videos related to

Sort By:
Pageof 28
Genomics|April 1, 1989
Analysis of somatic mutations at human minisatellite loci in tumors and cell linesJ A Armour, I Patel, S L Thein, et al.
Journal of Leukocyte Biology|May 21, 2015
Low DICER1 expression is associated with attenuated neutrophil differentiation and autophagy of NB4 APL cellsJulian Wampfler, Elena A Federzoni, Bruce E Torbett, et al.
British Journal of Cancer|April 19, 2014
Effects of erythropoiesis-stimulating agents on fatigue- and anaemia-related symptoms in cancer patients: systematic review and meta-analyses of published and unpublished dataJ Bohlius, T Tonia, E Nüesch, et al.
Leukemia|November 2, 2007
The hDMP1 tumor suppressor is a new WT1 target in myeloid leukemiasM P Tschan, U Gullberg, D Shan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 18, 2012
MicroRNA-381 represses ID1 and is deregulated in lung adenocarcinomaSacha I Rothschild, Mario P Tschan, Rolf Jaggi, et al.
British Journal of Haematology|November 25, 1998
Sampling bias and logistical problems of molecular analyses in a clinical leukaemia trial. Swiss Group for Clinical Cancer Research (SAKK)M F Fey, M Blaser, M Wernli, et al.
Lung Cancer (Amsterdam, Netherlands)|July 4, 2016
MicroRNA-106a targets autophagy and enhances sensitivity of lung cancer cells to Src inhibitorsSacha I Rothschild, Oliver Gautschi, Jasmin Batliner, et al.
Future Oncology (London, England)|February 5, 2014
Crizotinib inhibits migration and expression of ID1 in MET-positive lung cancer cells: implications for MET targeting in oncologyEmanuel Stutz, Oliver Gautschi, Martin F Fey, et al.
Blood|April 15, 1995
Interleukin-12 expression in human lymphomas and nonneoplastic lymphoid disordersJ Schwaller, A Tobler, G Niklaus, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|January 1, 1991
[Large cell anaplastic lymphomas in the immunocompromised host]B Borisch, M F Fey, A Tobler, et al.
Pageof 28